Rocket Lab (NASDAQ: RKLB) stock price has suffered a major reversal in the past few weeks, moving from the year-to-date high of $151 on May 27 to $84. This retreat continued even after the company landed a new NASA contract last week. So, is it safe to buy the dip or sell the rip? Rocket
Shares of advanced battery materials developer Solidion Technology STI swung sharply on Monday after the company announced plans to acquire a stake in SpaceX as a long-term treasury asset. It became the latest listed firm seeking exposure to Elon Musk’s aerospace company through its balance sheet. Solidion’s stock jumped more than 23% at one point,
Wall Street’s main indexes opened higher on Monday as easing tensions in the Middle East lifted investor sentiment after days of hostilities between the United States and Iran. Technology stocks also rebounded following a sharp selloff last week, while Comcast shares soared after the media and cable company announced plans to split into two publicly
Strategy Inc. MSTR shares (previously known as MicroStrategy) rose 2.7% in trading on Monday after the company announced a broad capital management overhaul. The plan aims to strengthen liquidity, support its preferred securities, and maintain long-term exposure to Bitcoin. The announcement follows a period of pressure on the company’s valuation. Strategy’s market capitalisation had fallen
Top software stocks have slumped this year amid the lingering concerns that artificial intelligence tools by companies like OpenAI and Anthropic will hurt their revenue growth in the long term. ServiceNow (NOW) stock is down by 35% this year, while Salesforce (CRM), Workday (WDAY), and Adobe (ADBE) have fallen by over 40%. NOW, CRM, WDAY,
South Korean stocks have soared in the past few months, with the KOSPI Index doubling this year, helped by the strong performance of Samsung and SK Hynix. It peaked at 9,388 this month and then pulled back to the current 8,410. Still, there is a risk that the index will retreat sharply once the ongoing
The S&P 500 Index has come under pressure in the past few days, moving from the year-to-date high of $7,620 to the current $7,354. This retreat continued amid the rising jitters that the AI boom is ending. This article highlights some of the top catalysts for the index and its ETFs like VOO and SPY.
Moderna Inc. (MRNA) shares surged nearly 10% on Friday, extending a powerful rally that has lifted the stock about 40% over the past month and significantly outperformed the broader market. The gains followed the company’s Science Day presentation and investor event, where Moderna outlined an ambitious strategy to expand beyond its COVID-19 vaccine business and
Apple Inc. (AAPL) shares have come under pressure after the company raised prices on several MacBook and iPad models. But some Wall Street analysts believe the pullback could present a buying opportunity as the company leverages its pricing power and loyal customer base. Apple stock fell 6.1% on Thursday after the company announced price increases
The Dow Jones Industrial Average and the broader US stock market closed lower on Friday as investors continued rotating out of technology and semiconductor stocks while shifting into more defensive sectors such as healthcare, consumer staples, and utilities. The S&P 500 slipped 0.27% to close at 7,337.68, while the Nasdaq Composite fell 0.48% to 25,236.88.